Folia Microbiologica

, Volume 58, Issue 2, pp 141–146 | Cite as

Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA + status and clinical outcome

  • Erkan YulaEmail author
  • Toğrul Nagiyev
  • Özlem Aycan Kaya
  • Melek İnci
  • M. Murat Çelik
  • Fatih Köksal


Helicobacter pylori was examined in 110 patients (82 (74.5) with gastritis, 18 (16.4) with duodenitis, six (5.5) with duodenal ulcer and gastroesophageal reflux, and four (3.6 %) with normal) with gastrointestinal problems living in rural area, no history of macrolide use, and detected by culture (71.8) or direct detection from gastric biopsies by PCR (82.7 %). Also, cagA gene was identified using PCR and was found positive in 68/91 (74.7 %) strains. The prevalence of clarithromycin-resistant H. pylori was investigated by two methods including PCR–RFLP (7.7 (A2142G 1.1 and A2143G 6.6 %)) and twofold agar dilution (8.9 %) to detect phenotypic and genotypic status simultaneously. Among all the H. pylori positive patients, eight (8.8 %) isolates were found to be resistant to clarithromycin by at least one of the AD and/or PCR–RFLP methods. H. pylori positive rates were significantly correlated with patients' sex, age, and endoscopic findings (p = 0.040, <0.001 and <0.001, respectively). There were no differences in gender or endoscopic findings related to cagA + and cagA patients. The gene of cagA was not significantly helpful in predicting the clinical outcome of H. pylori infection alone. In conclusion, we revealed that there was a low prevalence of primer clarithromycin resistance in patients living in rural area with no history of macrolide use. The prevalence of mutant strains among the macrolide-resistant H. pylori varies even geographically between close provinces.


Clarithromycin cagA Atrophic Gastritis Endoscopic Finding Macrolide Antibiotic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The authors have not declared any conflicts of interest.

Ethical standards

The experiments comply with the current laws of the Republic of Turkey.


  1. American Gastroenterological Association (1998) American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 114:579–581CrossRefGoogle Scholar
  2. Baglan PH, Bozdayi G, Ozkan M, Ahmed K, Bozdayi AM, Ozden A (2006) Clarithromycin resistance prevalence and iceA gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol 44:409–416PubMedGoogle Scholar
  3. Chomvarin C, Namwat W, Chaicumpar K et al (2008) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 12:30–36PubMedCrossRefGoogle Scholar
  4. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement, M100-S20. CLSI, Wayne, p 107Google Scholar
  5. De Francesco V, Giorgio F, Hassan C et al (2010) Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver Dis 19:409–414Google Scholar
  6. DeFrancesco V, Giorgio F, Ierardi E et al (2011) Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J Gastrointestin Liver Dis 20:235–239Google Scholar
  7. Erzin Y, Koksal V, Altun S et al (2006) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 11:574–580PubMedCrossRefGoogle Scholar
  8. Fluit AC, Visser MR, Schmitz FJ (2001) Molecular detection of antimicrobial resistance. Clin Microbiol Rev 14:836–871PubMedCrossRefGoogle Scholar
  9. Hybenova M, Hrda P, Potuznikova B, Pavlik E, Stejskal V, Dosedel J, Sterzl I (2010) Lymphocyte proliferative response to Helicobacter pylori antigens in H. pylori-infected patients. Folia Microbiol 55:649–656CrossRefGoogle Scholar
  10. Kaya AD, Öztürk CE, Akcan Y et al (2007) Prevalence of Helicobacter pylori in symptomatic patients and detection of clarithromycin resistance using melting curve analysis. Curr Ther Res 68:151–160CrossRefGoogle Scholar
  11. Lima VP, Silva-Fernandes IJ, Alves MK, Rabenhorst SH (2011) Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: an association with histopathological parameters. Cancer Epidemiol 35:e32–e37PubMedCrossRefGoogle Scholar
  12. Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M (1998) Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43:317–321PubMedCrossRefGoogle Scholar
  13. Malfertheiner P, Megraud F, O’Morain C, The European Helicobacter Study Group (EHSG) et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781PubMedCrossRefGoogle Scholar
  14. Matsunari O, Shiota S, Suzuki R et al (2012) Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol 50:876–883PubMedCrossRefGoogle Scholar
  15. Mishra S, Singh V, Rao GRK, Dixit VK, Gulati AK, Nath G (2008) Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol 8:815–819PubMedCrossRefGoogle Scholar
  16. Nagiyev T, Yula E, Abayli B, Koksal F (2009) Prevalence and genotypes of Helicobacter pylori in the gastric piopsy specimens from patients with gastroduodenal pathologies in Cukurova Region of Turkey. J Clin Microbiol 47:4150–4153PubMedCrossRefGoogle Scholar
  17. Nagiyev T, Köksal F, Abaylı B, Yula E (2010) Comparison of culture and GlmM-PCR methods for detecting Helicobacter pylori in antral and corpus biopsy specimens in patients with gastroduodenal disorders. Turk Klinikleri J Med Sci 30:919–924CrossRefGoogle Scholar
  18. Onder G, Aydin A, Akarca U, Tekin F, Ozutemiz O, Ilter T (2007) High Helicobacter pylori resistance rate to clarithromycin in Turkey. J Clin Gastroenterol 41:747–750PubMedCrossRefGoogle Scholar
  19. Owen RJ (2002) Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50:285–289PubMedCrossRefGoogle Scholar
  20. Saribasak H, Salih BA, Yamaoka Y, Sander E (2004) Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 42:1648–1651PubMedCrossRefGoogle Scholar
  21. Satomi S, Yamakawa A, Matsunaga S et al (2006) Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol 41:668–673PubMedCrossRefGoogle Scholar
  22. Sezgin O, Aslan G, Altıntaş E, Tezcan S, Serin MS, Emekdaş G (2008) Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol 19:163–167PubMedGoogle Scholar
  23. Versalovic J, Shortridge D, Kibler K et al (1996) Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 40:477–480PubMedGoogle Scholar
  24. Wong WM, Gu Q, Wang WH et al (2003) Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance. Clin Infect Dis 37:882–889PubMedCrossRefGoogle Scholar
  25. Xia Y, Yamaoka Y, Zhu Q, Matha I, Gao X (2009) A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One 4:e7736PubMedCrossRefGoogle Scholar
  26. Yucel T, Aygin D, Sen S, Yucel O (2008) The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 61:179–183PubMedGoogle Scholar
  27. Yula E, Nağıyev T, Köksal F (2010) Comparison of two different primer sets used for detection of Helicobacter pylori DNA by polymerase chain reaction assay in gastric tissues. Turk Klinikleri J Med Sci 30:1166–1170CrossRefGoogle Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2012

Authors and Affiliations

  • Erkan Yula
    • 1
    Email author
  • Toğrul Nagiyev
    • 2
  • Özlem Aycan Kaya
    • 3
  • Melek İnci
    • 1
  • M. Murat Çelik
    • 4
  • Fatih Köksal
    • 2
  1. 1.Department of Medical Microbiology, Faculty of MedicineUniversity of Mustafa KemalAntakyaTurkey
  2. 2.Department of Medical Microbiology, Faculty of MedicineUniversity of CukurovaAdanaTurkey
  3. 3.Department of Medical Parasitology, Faculty of MedicineUniversity of Mustafa KemalHatayTurkey
  4. 4.Department of Internal Medicine, Faculty of MedicineUniversity of Mustafa KemalHatayTurkey

Personalised recommendations